Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.
about
Animal models for Ebola and Marburg virus infectionsViral hemorrhagic fevers: advancing the level of treatmentThe 2014–2015 Ebola outbreak in West Africa: Hands OnEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentEbola haemorrhagic feverMonitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in LiberiasiRNA Versus miRNA as Therapeutics for Gene SilencingLipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectivesMouse models for filovirus infectionsDevelopment of RNA Aptamers Targeting Ebola Virus VP35Progress toward in vivo use of siRNAs-IINeglected filovirusesPreparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught UsProgress towards the treatment of Ebola haemorrhagic fever.Updates in diagnosis and management of Ebola hemorrhagic fever.Pertussis: Microbiology, Disease, Treatment, and Prevention.The Ebola virus VP35 protein is a suppressor of RNA silencing.Development and characterization of a mouse model for Marburg hemorrhagic feverIntracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis.Advances in Systemic siRNA DeliveryAttenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swineDrug delivery-mediated control of RNA immunostimulationSynthesis of lipid-oligonucleotide conjugates for RNA interference studies.Are we any closer to combating Ebola infections?Filovirus replication and transcription.Treatment of ebola virus disease.Enzymatically produced pools of canonical and Dicer-substrate siRNA molecules display comparable gene silencing and antiviral activities against herpes simplex virus.Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primatesStructures of protective antibodies reveal sites of vulnerability on Ebola virus.Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach.Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus.Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics.Lentviral-mediated RNAi to inhibit target gene expression of the porcine integrin αv subunit, the FMDV receptor, and against FMDV infection in PK-15 cells.Harnessing RNAi nanomedicine for precision therapyHydrophobization and bioconjugation for enhanced siRNA delivery and targetingPostexposure treatment of Marburg virus infectionThe Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United StatesPotential vaccines and post-exposure treatments for filovirus infections.A Syrian golden hamster model recapitulating ebola hemorrhagic fever.
P2860
Q21131118-86DCA662-7EB8-46E8-AE76-413F6B10684AQ21245298-9D0F6304-F9CA-4206-9F09-93B1F094C599Q24049114-B5D2FDDF-F76C-4F5F-82D0-FEAC08EB9D1BQ24597625-06F3F69D-BC5B-41E1-B72C-EE4298585B5CQ24629338-6EC0A54E-A847-4CC3-853D-216F77904C65Q24696012-6F6BE361-9FF5-4000-9E44-256ABE101D2BQ26786876-ECBA67ED-B478-43E3-9E23-D0EDFB64F35CQ26859021-DE8329E2-8DC0-441C-8F4D-24A322A087FEQ27011569-49D40017-1887-4668-A92A-5CA8039E95DBQ27680060-87E84ADB-40A3-415F-A54F-F3564E8BB9E8Q28255877-0CFDD6CE-12EE-4C3D-A8CF-B87EDCC996BCQ28383265-36A4D35A-3711-4479-8A9F-29374D72E5B9Q28397866-3CBDBC74-5729-42C9-BF83-A00D42D39D02Q30230272-6BA6FB85-F1C7-4605-9FC7-400C8CE56FA7Q30238537-94432C1C-E2D4-455D-A046-642EC157CEB2Q30251684-8E812926-8D41-4E82-9BDF-A3996242546BQ33288729-7663E67D-72F2-4D99-BF75-0FCAF62109B7Q33384111-5A8B903C-179C-4BD4-906E-8FD1845C68D2Q33523028-ED20EDAD-313E-4C25-B478-990BE31CBB70Q33613316-C4168A49-0F73-4BE6-B923-FEA89094BDDDQ33676729-7F31FD89-40CE-43E6-8C53-776823C91A87Q33713938-C5BFDF64-F066-4566-9BC4-EA1F60BE6F67Q33825496-48DEBFC3-9548-4E30-8B53-04DCA953D056Q34022601-081D060A-D9D3-488E-AD2F-230CA1FD8188Q34375243-42DEA774-F2A9-48C0-85A0-E129F8BE68CFQ34460182-1A2FE219-13D4-493D-B597-D05428FF18ACQ34506213-A59FFE9F-D2EC-4C22-98CF-B5EF338F37B1Q34589949-75A48BB7-B9D9-40DD-BACB-0F0977FB0641Q34661120-7F9EFDA7-63E7-4760-A778-2B0A7E3E2F40Q34741896-C54F7A32-170D-48FB-BCC3-76061922C34CQ34971349-3B1C96A4-750D-417C-A903-30EADD159258Q34990686-0A06B4AB-9331-4119-B217-C447803DFB90Q35038226-E10B44FC-C10E-4001-8FC9-9DDA13709609Q35241638-2EDEA6A6-7BF7-439C-B167-D510FD473F87Q35673875-D43D21E6-D5AD-45D5-96B7-B65905CA3F93Q35697443-7D425F71-4A9A-4A22-83A2-27659A4034FAQ35877126-884744F9-13EB-4D9D-818B-B06D38C3153FQ35974433-DD07D088-EA15-457C-8AD1-E708A50B60A4Q36404178-9833422E-B715-424D-87C3-375EDBF16AEEQ36495558-83E87C6F-EF03-4A38-84D2-E3233E5E2532
P2860
Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Postexposure protection of gui ...... conferred by RNA interference.
@ast
Postexposure protection of gui ...... conferred by RNA interference.
@en
Postexposure protection of gui ...... conferred by RNA interference.
@nl
type
label
Postexposure protection of gui ...... conferred by RNA interference.
@ast
Postexposure protection of gui ...... conferred by RNA interference.
@en
Postexposure protection of gui ...... conferred by RNA interference.
@nl
prefLabel
Postexposure protection of gui ...... conferred by RNA interference.
@ast
Postexposure protection of gui ...... conferred by RNA interference.
@en
Postexposure protection of gui ...... conferred by RNA interference.
@nl
P2093
P50
P356
P1476
Postexposure protection of gui ...... conferred by RNA interference.
@en
P2093
Adam Judge
Amy C H Lee
Elizabeth A Fritz
Elliott Kagan
Erik Zhaoying Yu
Ian MacLachlan
Janet R Phelps
Joan B Geisbert
Kevin McClintock
Lloyd B Jeffs
P304
P356
10.1086/504267
P407
P577
2006-05-10T00:00:00Z